Johnson & Johnson Medical Devices has rebranded as Johnson & Johnson MedTech as the unit moves deeper into digital technology.
New Brunswick, New Jersey-based Johnson & Johnson (NYSE: JNJ) noted the coming change in its 2022 annual report published last month, saying the switch would take effect in the company’s first fiscal quarter.
That preview was followed by an announcement of approximately 100 words, mostly attributed to Johnson & Johnson MedTech EVP and Executive Chair Ashley McEvoy.
Johnson & Johnson provided more information to Medical Design & Outsourcing today.